Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
- Resource Type
- Abstract
- Source
- In
Canadian Journal of Diabetes November 2021 45(7) Supplement:S15-S16 - Subject
- Language
- ISSN
- 1499-2671